CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Reproduction, Fertility and Development   
Reproduction, Fertility and Development
  Vertebrate Reproductive Science & Technology
blank image Search
blank image blank image
blank image
  Advanced Search

Journal Home
About the Journal
Editorial Structure
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Virtual Issues
Sample Issue
For Authors
General Information
Submit Article
Author Instructions
Open Access
Awards and Prizes
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

blue arrow e-Alerts
blank image
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

red arrow Connect with SRB
blank image
facebook TwitterIcon

Affiliated Societies

RFD is the official journal of the International Embryo Transfer Society and the Society for Reproductive Biology.

Article << Previous     |     Next >>   Contents Vol 22(1)


A. M. Gimenes A, F. S. Ignacio A, A. L. N. Boff A, D. R. Bergfelt B and C. Meira A

A School of Veterinary Medicine and Animal Science, Sao Paulo State University - UNESP, Department of Animal Reproduction and Veterinary Radiology, Botucatu, São Paulo, Brazil;
B Repro Endo-To, Ashburn, VA, USA

Export Citation


The present study aimed to evaluate the ovarian response to relatively low doses of equine pituitary extract (EPE) involving 40 estrous cycles in 15 horse mares. The mares were Mangalarga Marchador and ranged in age from 5 to 24 years. Transrectal ultrasonography was used at 24-h intervals to monitor follicular development and to detect ovulations (Day 0). On Day 8, all mares received 7.5 mg i.m. of dinoprost tromethamine (Lutalyse®, Pfizer, Paulínia, Brasil) and were randomly assigned to treatment and control groups as follows: Groups 1 and 2 (n = 8 cycles/group) received 6 mg of EPE i.m. twice daily, beginning when the largest follicle was 20 to 23 mm (Group 1) or regardless of follicle size on Day 8 (Group 2); Groups 3 and 4 (n = 8 cycles/group) received 8 mg of EPE i.m. twice daily, beginning when the largest follicle was 20 to 23 mm (Group 3) or regardless of follicle size on Day 8 (Group 4); Group 5 (control; n = 8 cycles) received saline i.m. starting on Day 8. Treatments with EPE or saline continued until the largest follicle reached ≥35 mm, at which time a single dose of hCG (2500 IU i.v. Vetecor®, Hertape Calier Saúde Animal S/A, Juatuba, Brasil) was given. Groups were compared using ANOVA and mean differences among groups were located with ScottKnott test. There was an effect of group (P < 0.05) for number of follicles >30 mm, ovulations, and days of treatment as indicated in the table. In conclusion, starting EPE treatment with 8 mg (16 mg day-1) when the largest follicle reached 20 to 23 mm (Group 3) was the most effective for enhancing the number of >30 mm follicles and ovulations with minimal days of treatment.

FAPESP and JM Farm for funding the project.

Reproduction, Fertility and Development 22(5305) 362–362   http://dx.doi.org/10.1071/RDv22n1Ab410
Published online: 08 December 2009

Top  Email this page

Legal & Privacy | Contact Us | Help


© CSIRO 1996-2015